Aleplasinin 是纤溶酶原激活物抑制剂 1 (PAI-1) 的选择性和口服活性抑制剂，是纤溶系统的关键负调节剂。 Aleplasinin 可用于阿尔茨海默病研究。

Aleplasinin is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies.

481629-87-2

C28H27NO3

425.52

PAZ 417;PAZ417;PAZ-417

DMSO:245 mg/mL (575.77 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years